CLEVELAND, Nov. 20, 2014 /PRNewswire/ –
DATATRAK International, Inc. (OTCQX: DTRK), the
leader in developing cloud-based, unified
eClinical® technologies and delivering related
services for the clinical trials industry, today announced that its
Chairman and CEO, Mr. Laurence P.
Birch, will present at the LD Micro Conference on
December 3, 2014, at 5:30pm PST / 8:30pm
EST, in Los Angeles.
"DATATRAK continues to transform the eClinical
industry," said Mr. Birch. "Our unified
eClinical® solutions deliver differentiated benefits
to the clinical trials industry, reinforced by our expanded and
strengthened Data Unifier Patent Portfolio.
DATATRAK reduces complexities, delivering time and
cost savings and a superior user experience, all of which lead to
better site compliance, better data, and ultimately a safer trial.
And only DATATRAK offers the Unified
Experience™ – and that's great news for customers and investors
alike."
"We are honored to have DATATRAK International
present at the Main Event this year," stated Chris Lahiji, Founder of LD Micro.
The DATATRAK ONE® Unified Platform is the foundation of
DATATRAK efficiencies, providing a single data source
that powers all DATATRAK solutions, eliminating
data integration. We offer industry-leading system
reliability powered by the cloud, with an exceptional User
Interface and a greater overall value.
Join DATATRAK Thought Leaders:
- Twitter
- LinkedIn
- SlideShare
- The DATATRAK
Blog
Tweet: DATATRAK #UnifiedExperience to be presented at LD Micro
conference http://bit.ly/1thffzK
About
DATATRAK International,
Inc.
DATATRAK International is a worldwide
technology and services company delivering unified
eClinical® solutions and related services for the
clinical trials industry. DATATRAK built its
multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via
DATATRAK's Clinical and Consulting Services group.
The Company delivers a complete portfolio of software products
designed to accelerate the reporting of clinical research data from
sites to sponsors and ultimately regulatory authorities, faster and
more efficiently than loosely integrated technologies. The
DATATRAK ONE® software solution,
deployed worldwide through an ASP or Enterprise Transfer offering,
supports Preclinical and Phase I - Phase IV drug and device studies
in multiple languages throughout the world. DATATRAK
is located in Cleveland, Ohio;
Bryan, Texas; Cary (RTP),
North Carolina, Chicago, Illinois; and London, England. For more information,
visit http://www.datatrak.com.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates
and current beliefs concerning the operations, future results and
prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are
beyond the control of the Company, and which could cause actual
results to differ materially from those contemplated in these
forward-looking statements. For a list of certain factors that may
cause actual results to differ materially from those contemplated
in these forward looking statements, please see the Company's
report filed with the OTCQX Market on November 13, 2014 announcing its results for the
third quarter 2014. The Company undertakes no obligation to update
publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.